Paper
Dalton Transactions
1
8 L. Zayat, M. G. Noval, J. Campi, C. I. Calero, D. J. Calvo and 30 J. Wei and A. K. Renfrew, Photolabile Ruthenium
R. Etchenique, A New Inorganic Photolabile Protecting
Group For Highly Efficient Visible Light GABA Uncaging,
ChemBioChem, 2007, 8(17), 2035–2038.
Complexes To Cage And Release A Highly Cytotoxic
Anticancer Agent, J. Inorg. Biochem., 2018, 179, 146–
153.
1
9 M. A. Sgambellone, A. David, R. N. Garner, K. R. Dunbar 31 J. J. Woods, J. Cao, A. R. Lippert and J. J. Wilson,
and C. Turro, Cellular Toxicity Induced By The
Photorelease Of A Caged Bioactive Molecule: Design Of A
Potential Dual-Action Ru(II) Complex, J. Am. Chem. Soc.,
Characterization And Biological Activity Of A Hydrogen
Sulfide-Releasing Red Light-Activated Ruthenium(II)
Complex, J. Am. Chem. Soc., 2018, 140(39), 12383–12387.
32 R. N. Garner, C. G. Pierce, C. R. Reed and
W. W. Brennessel, Photoinitiated Treatment Of
Mycobacterium Using Ru(II) Isoniazid Complexes, Inorg.
Chim. Acta, 2017, 461, 261–266.
2
013, 135(30), 11274–11282.
0 H. Chan, J. B. Ghrayche, J. Wei and A. K. Renfrew,
Photolabile Ruthenium(II)–Purine Complexes:
2
2
2
Phototoxicity, DNA Binding, And Light-Triggered Drug
Release, Eur. J. Inorg. Chem., 2017, 2017(12), 1679–1686.
33 T. N. Rohrabaugh, A. M. Rohrabaugh, J. J. Kodanko,
J. K. White and C. Turro, Photoactivation If Imatinib–
Antibody Conjugate Using Low-Energy Visible Light From
Ru(II)-Polypyridyl Cages, Chem. Commun., 2018, 54(41),
5193–5196.
1 N. Karaoun and A. K. Renfrew,
A
Luminescent
Ruthenium(II) Complex For Light-Triggered Drug Release
And Live Cell Imaging, Chem. Commun., 2015, 51(74),
1
4038–14041.
2 T. Respondek, R. N. Garner, M. K. Herroon, I. Podgorski, 34 P. Resa-Infante, N. Jorba, R. Coloma and J. Ortin, The
C. Turro and J. J. Kodanko, Light Activation Of A Cysteine
Influenza Virus RNA Synthesis Machine, RNA Biol., 2011,
8(2), 207–215.
Protease Inhibitor: Caging Of A Peptidomimetic Nitrile
II
With Ru (bpy)
2
, J. Am. Chem. Soc., 2011, 133(43), 17164– 35 S. J. Plotch, M. Bouloy, I. Ulmanen and R. M. Krug, A
1
7167.
Unique Cap (m7GpppXm)-Dependent Influenza Virion
2
2
2
3 B. S. Howerton, D. K. Heidary and E. C. Glazer, Strained
Ruthenium Complexes Are Potent Light-Activated
Anticancer Agents, J. Am. Chem. Soc., 2012, 134(20), 8324–
Endonuclease Cleaves Capped RNAs To Generate The
Primers That Initiate Viral RNA Transcription, Cell, 1981,
23(3), 847–858.
8
327.
36 A. Dias, D. Bouvier, T. Crépin, A. A. McCarthy, D. J. Hart,
F. Baudin, S. Cusack and R. W. H. Ruigrok, The Cap-
Snatching Endonuclease Of Influenza Virus Polymerase
Resides In The PA Subunit, Nature, 2009, 458(7240), 914–
918.
4 A. Zamora, C. A. Denning, D. K. Heidary, E. Wachter,
L. A. Nease, J. Ruiz and E. C. Glazer, Ruthenium-
Containing P450 Inhibitors For Dual Enzyme Inhibition
And DNA Damage, Dalton Trans., 2017, 46(7), 2165–2173.
5 M. Huisman, J. K. White, V. G. Lewalski, I. Podgorski, 37 P. Yuan, M. Bartlam, Z. Lou, S. Chen, J. Zhou, X. He, Z. Lv,
C. Turro and J. J. Kodanko, Caging The Uncageable: Using
Metal Complex Release For Photochemical Control Over
Irreversible Inhibition, Chem. Commun., 2016, 52(85),
R. Ge, X. Li, T. Deng, E. Fodor, Z. Rao and Y. Liu, Crystal
Structure Of An Avian Influenza Polymerase PAN Reveals
An Endonuclease Active Site, Nature, 2009, 458(7240), 909–
913.
1
2590–12593.
2
6 V. H. S. van Rixel, V. Ramu, A. B. Auyeung, N. Beztsinna, 38 D. Guilligay, F. Tarendeau, P. Resa-Infante, R. Coloma,
D. Y. Leger, L. N. Lameijer, S. T. Hilt, S. E. Le Dévédec,
T. Yildiz, T. Betancourt, M. B. Gildner, T. W. Hudnall,
V. Sol, B. Liagre, A. Kornienko and S. Bonnet, Photo-
Uncaging Of A Microtubule-Targeted Rigidin Analogue In
T. Crepin, P. Sehr, J. Lewis, R. W. H. Ruigrok, J. Ortin,
D. J. Hart and S. Cusack, The Structural Basis For Cap
Binding By Influenza Virus Polymerase Subunit PB2, Nat.
Struct. Mol. Biol., 2008, 15(5), 500–506.
Hypoxic Cancer Cells And In A Xenograft Mouse Model, 39 C. V. Credille, Y. Chen and S. M. Cohen, Fragment-Based
J. Am. Chem. Soc., 2019, 141(46), 18444–18454.
Identification Of Influenza Endonuclease Inhibitors,
2
7 L. N. Lameijer, D. Ernst, S. L. Hopkins, M. S. Meijer,
J. Med. Chem., 2016, 59(13), 6444–6454.
S. H. C. Askes, S. E. Le Dévédec and S. Bonnet, A Red-Light- 40 A. Monod, C. Swale, B. Tarus, A. Tissot, B. Delmas,
Activated Ruthenium-Caged NAMPT Inhibitor Remains
Phototoxic In Hypoxic Cancer Cells, Angew. Chem., Int. Ed.,
R. W. Ruigrok, T. Crépin and A. Slama-Schwok, Learning
From Structure-Based Drug Design And New Antivirals
Targeting The Ribonucleoprotein Complex For The
Treatment Of Influenza, Expert Opin. Drug Discovery, 2015,
10(4), 345–371.
2
017, 56(38), 11549–11553.
2
8 J. D. Knoll, B. A. Albani, C. B. Durr and C. Turro, Unusually
Efficient Pyridine Photodissociation From Ru(II) Complexes
With Sterically Bulky Bidentate Ancillary Ligands, J. Phys. 41 J. C. Jones, B. M. Marathe, C. Lerner, L. Kreis, R. Gasser,
Chem. A, 2014, 118(45), 10603–10610.
P. N. Q. Pascua, I. Najera and E. A. Govorkova, A Novel
Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-
Influenza Virus Activity In Vitro, Antimicrob. Agents
Chemother., 2016, 60(9), 5504–5514.
2
9 A. Li, R. Yadav, J. K. White, M. K. Herroon, B. P. Callahan,
I. Podgorski, C. Turro, E. E. Scott and J. J. Kodanko,
Illuminating Cytochrome P450 Binding: Ru(II)-Caged
Inhibitors Of CYP17A1, Chem. Commun., 2017, 53(26), 42 D. L. Hughes, Review Of The Patent Literature: Synthesis
3
673–3676.
And Final Forms Of Antiviral Drugs Tecovirimat And
2764 | Dalton Trans., 2021, 50, 2757–2765
This journal is © The Royal Society of Chemistry 2021